FL56+FL57= in­fi­nite pos­si­bil­i­ties? Flag­ship's hy­brid start­up takes ma­chine learn­ing in drug dis­cov­ery to the next lev­el — and Covid-19 of­fers a quick test

On his fac­ul­ty di­rec­to­ry page at Dart­mouth, Gevorg Grig­o­ryan is un­equiv­o­cal about his key fas­ci­na­tion: “un­der­stand­ing the lan­guage of pro­teins.”

For the long­time re­searcher of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER